Abstract:Objective We performed a prospective observational study to explore the prognostic value of plasma galectin-3, a biomarker for fibrosis and inflammation, in Chinese patients with heart failure (HF).Methods and results Galectin-3, N-terminal pro B-type natriuretic peptide (NT-proBNP) and other clinically related variables were measured in consecutive HF patients in Beijing Hospital. Specifically, galectin-3 was detected by an enzyme-linked immunosorbent assay. The primary end point was major adverse cardiac events (MACE), including all-cause mortality or readmission at the end of follow-up. The secondary end point was all-cause mortality. The adjusted hazard ratio (HR) was determined by COX regression model. In total, 272 patients were included in this study with a median age of 77 years, of whom 55.9% were male. During a median follow-up of 584 (415-813) days, 53 patients (19.5%) died and 103 patients (37.9%) died and/or required readmission. Plasma galectin-3 levels by tertiles were associated with an increased risk for the primary end point (P < 0.001). Kaplan-Meier survival curves showed that the third tertile of galectin-3 was associated with an increased rate of MACE, compared with the first and second tertiles, with the log rank P < 0.001 and P = 0.001, respectively. In addition, the multivariate COX regression model showed that the highest tertile of galectin-3 was associated with an increased risk for MACE (HR = 2.13, 95% confidence interval: 1.24-3.68, P = 0.006), compared with the lowest tertile after adjustment for age, NT-proBNP, creatinine, uric acid, albumin, haemoglobin, and estimated glomerular filtration rate (eGFR).Conclusion Plasma galectin-3 is an independent predictor of all-cause mortality and/or readmission in Chinese patients with HF.

Unlocking the role of Galectin-3: Implications for sleep disorders and health

Association between sleep patterns and galectin-3 in a Chinese community population

Role of galectin-3 as a biomarker in obstructive sleep apnea: a systematic review and meta-analysis

Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)

Sleep apnea and galectin-3: possible sex-specific relationship

Galectin-3 and Inflammation

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update

Understanding Galectin-3's Role in Diastolic Dysfunction: A Contemporary Perspective

Emerging Roles of Galectin-3 in Pulmonary Diseases

Emerging role of galectin 3 in neuroinflammation and neurodegeneration

Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis

The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease

Unraveling the role of galectin-3 in cardiac pathology and physiology

Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target

Galectin-3 in Cardiovascular Diseases

Galectin-3: action and clinical utility in chronic kidney disease

Galectin‐3 and Risk of Atrial Fibrillation: A Systematic Review and Meta‐analysis

A link between sleep loss, glucose metabolism and adipokines

Exploratory Assessment of Galectin-1, -3, and -9 in Non-Small Cell Lung Cancer

Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions

Prognostic Value of Galectin-3 on Admission in Chinese Patients with Heart Failure: a Prospective Observational Study